Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response
Cancer Letters · 2025-08 · 625 · 217759
DOI: 10.1016/j.canlet.2025.217759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025-08. Verfasst von Mengmeng Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Acad…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-bcl-2, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
- Department of Radiation Oncology, Shandong University Cancer Center, Jinan, Shandong, China.
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. Electronic address: s…
- Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. Electronic address: y…
- Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China; Department of Radiati…
Förderung
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Ma, M., Zhang, Z., Tian, C., Liu, X., Wu, M., Yu, J., Yuan, J., & Chen, D. (2025). Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response. Cancer Letters, 625, 217759. https://doi.org/10.1016/j.canlet.2025.217759
Vancouver
Ma M, Zhang Z, Tian C, Liu X, Wu M, Yu J, et al. Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response. Cancer Letters. 2025;625:217759. doi:10.1016/j.canlet.2025.217759
BibTeX
@article{Ma2025,
author = {Ma, Mengmeng and Zhang, Zengfu and Tian, Chen and Liu, Xu and Wu, Meng and Yu, Jinming and Yuan, Jupeng and Chen, Dawei},
title = {Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response},
journal = {Cancer Letters},
year = {2025},
volume = {625},
pages = {217759},
doi = {10.1016/j.canlet.2025.217759}
}
EUVIMED